Talent Pool

Contributed by:

NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.

Pharmaceutical POOL

Dr. Charles BOWDEN
Peter TAM
Vivus Announces Two Promotions
Vivus, a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, has promoted two of its senior executives. Charles Bowden, M.D., has been promoted to senior director, clinical development, from director, clinical development. Dr. Bowden has assumed responsibility for Phase III clinical studies of avanafil for the treatment of erectile dysfunction, and he continues to lead Vivus’ efforts in experimental medicine. He received an M.D. from Baylor College of Medicine. Peter Tam has been promoted to chief operating officer from senior VP of product and corporate development. Mr. Tam retains overall responsibility for business development, clinical and preclinical development, regulatory affairs and chemistry, manufacturing, and controls. He received an MBA from Santa Clara University. Dr. D. Gary GILLILAND Merck Appoints Oncology Researcher Oncology researcher and physician D. Gary Gilliland, M.D., Ph.D., has joined Merck as senior VP of Merck Research Laboratories (MRL) and oncology franchise head. Dr. Gilliland leads the implementation of Merck’s oncology research strategy and serves as a member of Merck’s research management committee. Dr. Gilliland comes to Merck after almost 20 years on the faculty at Harvard. While there, he was professor of medicine at Harvard Medical School and professor of stem cell and regenerative biology at Harvard University. He is also an investigator of the Howard Hughes Medical Institute, director of the leukemia program at the Dana-Farber/Harvard Cancer Center, and director of the cancer stem cell program of the Harvard Stem Cell Institute. Dr. Gilliland received his Ph.D. in microbiology from the University of California, Los Angeles. He received his M.D. from the University of California, San Francisco. Biotechnology POOL Dr. Jennifer DOUDNA Genentech Strengthens Research Team Jennifer Doudna, Ph.D., has joined global biotechnology company Genentech as VP, discovery research, overseeing the departments of protein chemistry and structural biology. In this newly created role, Dr. Doudna also serves as a member of the small molecule drug discovery senior leadership team and participates in therapeutic RNA discovery efforts. Dr. Doudna comes to Genentech from the University of California, Berkeley, where she served as a professor in the Departments of Molecular and Cell Biology and Chemistry, as well as a Howard Hughes Medical Institute investigator. She earned a Ph.D. in biochemistry from Harvard University. Biopharmaceutical POOL Dr. Andrew CHENG Gilead Sciences Promotes Development VP Gilead Sciences, a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need, has promoted Andrew Cheng, M.D., Ph.D., to senior VP, development operations, from VP, clinical research. Dr. Cheng is responsible for Gilead’s biometrics, clinical operations, drug safety and public health, project and portfolio management, and regulatory affairs activities. He received a medical degree and a Ph.D. in cellular and molecular biology from Columbia University. William FLETCHER NTI Taps Director as Acting CEO Neurobiological Technologies (NTI) has appointed William Fletcher acting CEO, and its board has discontinued its previously announced search for a permanent, full-time president and CEO. Mr. Fletcher has served as chairman of Teva Pharmaceuticals North America since 2004, and as a director of NTI since 2007. Mr. Fletcher is working with NTI’s board to evaluate alternatives and determine the best direction for NTI following the failure of its Viprinex program, which was in Phase III clinical trials for stroke. David HOLTZ Nucryst Selects CFO as Interim Chief Executive Nucryst Pharmaceuticals has selected VP and Chief Financial Officer David Holtz to serve as interim president and CEO, replacing departing Chairman, President, and CEO Thomas Gardner. Neil Carragher, currently lead director of Nucryst, has assumed the role of chairman. Mr. Holtz retains his role as chief financial officer of the company. Nucryst develops, manufactures, and commercializes medical products that fight infection and inflammation using Silcryst, an atomically disordered nanocrystalline silver technology. Specialty POOL Chris MARIO Neuropharm Names Brand Leader in U.S. Office Neuropharm Group, a U.K.-based specialty pharmaceutical company focused on the development of medicines for the treatment of neurodevelopmental disorders, has appointed Chris Mario brand leader within its U.S. operating unit, Neuropharm Inc. Ms. Mario brings to Neuropharm more than two decades of experience in pharmaceutical marketing and sales, most recently as executive director of U.S. and global marketing within Wyeth Pharmaceuticals’ biopharma business unit. She joins Neuropharm as it prepares to apply for U.S. approval of NPL-2008 for the treatment of autism in the second quarter of 2009. Dr. Bruce MORRA New Chief Executive at Scolr Pharma Scolr Pharma has appointed Bruce Morra, Ph.D., MBA, president and CEO. Scolr Pharma is a specialty pharmaceutical company that combines its formulation expertise and its patented CDT platform to develop novel pharmaceutical, over-the-counter, and nutritional products. Dr. Morra has extensive experience in the pharmaceutical, medical device, biotechnology, and polymers industries, and has served as a member of the Scolr Pharma board of directors since August 2007. He received an MBA and a Ph.D. in polymer science and engineering from the University of Massachusetts at Amherst Agency POOL Michael BURCHILL Joel CONSTANTZ Dawn MChugh Doug MCINTOSH Abby MORRIS Roxane PADGETT Clint SMITH Chris SONDERMAN GSW Adds Staff in Three Locations Healthcare advertising agency GSW Worldwide, an inVentiv Health company, has announced a number of additions across three offices. Michael Burchill has been named senior interactive art director for GSW’s Newtown, Pa., office. Mr. Burchill previously worked for inVentiv sister agency Ignite Health as associate creative director. At GSW’s Columbus, Ohio, headquarters, Joel Constantz has been named VP, senior planner. Mr. Constantz previously served as senior VP, director of strategic planning, for Tierney Communications. Dawn McHugh has joined GSW’s New York office as VP, account director. Ms. McHugh previously served as VP, account supervisor, for Draftfcb Healthcare. She received a master’s degree from Hofstra University. Doug McIntosh has joined GSW’s Columbus office as VP, account director, from the same position at The Cartel Group. Abby Morris has been named account executive in the Columbus office. Previously, Ms. Morris was talent acquisition manager for Taylor Search Partners. Also in Columbus, Roxane Padgett has been appointed VP, account director. Ms. Padgett was most recently global team leader for Dell. She holds a master’s degree from Crown College. In the Newtown office, Clint Smith has been named senior editor. Mr. Smith was most recently group editorial supervisor for CDM Princeton. Chris Sonderman has been named senior brand designer in the Columbus office. Mr. Sonderman most recently served as lead creative for Swingtop. Christine DONNELLAN Navicor Adds to Creative Team Christine Donnellan has joined the Navicor Group as associate creative director. Ms. Donnellan previously served as senior VP, group creative director, for Sudler & Hennessey. Navicor, an inVentiv Health company, is a healthcare advertising agency specializing in oncology and immunology. Isabelle SIMON New VP at Publicis Groupe Isabelle Simon has joined Paris-based global communications group Publicis Groupe as senior VP, with responsibility for overseeing the mergers and acquisitions and legal departments, and monitoring minority holdings and the company’s external development strategy. Ms. Simon is a Harvard Law School graduate and a member of the bar in New York and Paris. Ms. Simon also holds post-master degrees in English and North American business law and international tax law. CRO POOL Allen ROSENSTON Industry Veteran Joins Halo Pharmaceutical Specialty contract pharmaceutical manufacturer Halo Pharmaceutical has appointed Allen Rosenston VP of business development. Mr. Rosenston joins Halo after a long career at Abbott Laboratories, during which he developed Abbott’s domestic contract pharmaceutical manufacturing business unit. Halo offers contract manufacturing, early-stage formulation development, and laboratory services to the pharmaceutical and related industries. Media POOL Amy Clarke LUCHSINGER Wolters Kluwer Health Names Sales VP for Lippincott Journals Wolters Kluwer Health has appointed Amy Clarke Luchsinger VP of sales, with responsibility for overseeing sales, promotion, and marketing efforts for the Lippincott Williams & Wilkins line of medical and health sciences journals. Ms. Luchsinger previously served as senior VP of Quadrant HealthCom. Wolters Kluwer Health provides information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, pharmacy, and the pharmaceutical industry. Service POOL Dr. Srinivas AKKARAJU NLV Partners Names West Coast Director New Leaf Venture Partners (NLV Partners), a life science-dedicated venture capital firm, has appointed Srinivas Akkaraju, M.D., Ph.D., as managing director and lead of NLV Partners’ West Coast biopharmaceuticals practice in Menlo Park, Calif. Dr. Akkaraju has more than 11 years of experience in life-sciences investing and business development. Before joining NLV Partners, Dr. Akkaraju was a cofounder and managing director of Panorama Capital. He received an M.D. and a Ph.D. in immunology from Stanford University School of Medicine. Susan EDWARDS Craig PYNE Datatrial Bolsters North American Presence As part of an ongoing initiative to expand its footprint and strengthen its data management resources within North America, clinical data solutions and services provider Datatrial has added key personnel and moved to a larger office space in Raleigh, N.C. Susan Edwards, manager of study delivery based at Datatrial’s U.K. headquarters, has been relocated to Raleigh to help the office meet the increased demand from U.S.-based clients. Datatrial also has hired Craig Pyne as general manager responsible for overseeing the growth of the new office in the United States and helping to reinforce the company’s global team. Most recently, Mr. Pyne was a consultant to companies looking to improve their customer experience and service. Richard MICALI New Sales VP at PDI PDI, a provider of contract sales and commercialization services to the biopharmaceutical industry, has named Richard Micali as senior VP of sales services. Before joining PDI, Mr. Micali was a 25-year veteran of Bristol-Myers Squibb, most recently serving as VP, sales. He received an MBA from John Carroll University. F Pharmaceutical POOL Mark ALTMEYER Otsuka America Selects Former BMS Executive as CEO Otsuka America Pharmaceutical (OAPI) has appointed Mark Altmeyer as president and CEO. Mr. Altmeyer succeeds interim President and CEO Dean Haubrich, Ph.D., who has been named chairman of the OAPI board. Mr. Altmeyer joins OAPI from Bristol-Myers Squibb, where he spent 16 years promoting and developing neuroscience, oncology, and metabolic/cardiovascular brands, most recently as senior VP, global commercialization for oncology. He received an MBA from Harvard Business School. OAPI, the North American arm of Japan’s Otsuka Pharmaceutical Co. Ltd., is a healthcare company that commercializes Otsuka-discovered and other product opportunities in North America. Enrique CONTERNO New President at Lilly USA Eli Lilly has promoted Enrique Conterno to president of Lilly USA LLC, succeeding Deirdre Connelly, who recently joined GlaxoSmithKline as president of its North American pharmaceuticals business. Mr. Conterno first joined Lilly in 1992 as a sales representative and most recently served as senior VP of healthcare professional markets for Lilly in the United States. He holds an MBA from Duke University. Dr. Matthew WIKLER OneWorld Health Appoints Medical Chief The Institute for OneWorld Health, a nonprofit pharmaceutical company that develops drugs for people living in the developing world who are afflicted by neglected infectious diseases, has named Matthew Wikler, M.D., MBA, FIDSA, chief medical officer. Most recently, Dr. Wikler served as president and CEO of Pacific Beach BioSciences. Dr. Wikler received an M.D. from Temple University and an MBA from the Wharton School of the University of Pennsylvania. Biotechnology POOL Matthew EMMENS Former Shire CEO Joins Vertex as President Biotechnology company Vertex Pharmaceuticals has named a successor to Founder, President, CEO, and Chairman Joshua Boger, Ph.D. Matthew Emmens, who recently joined Vertex as president, will assume the roles of CEO and chairman upon Dr. Boger’s retirement in May. Mr. Emmens was previously CEO of Shire. Dr. Lex VAN DER PLOEG Abraxis Health Expands Management Global biotechnology company Abraxis BioScience has named Lex Van der Ploeg, Ph.D., as senior VP of integrative medicine and translational science at its spinoff, Abraxis Health. Dr. Van der Ploeg is responsible for building and integrating Abraxis Health’s evidenced-based medicine capabilities, drug-discovery efforts, and external partnerships that serve as the foundation through which the spinoff will deliver personalized healthcare to patients. Dr. Van der Ploeg was most recently VP, basic research, and site head for Merck Research Laboratories’ Boston-based facility. He received an M.S. in biochemistry from the University of Amsterdam and a Ph.D. in biochemistry/enzymology/genetics from the University of Amsterdam/Netherlands Cancer Research Center. Biopharmaceutical POOL Dr. Frida GRYNSPAN Human Cell Therapy Expert Assumes Research VP Role at Pluristem Pluristem Therapeutics, a biotherapeutics company dedicated to the commercialization of unrelated donor-patient cell therapy products for a variety of disorders, has named Frida Grynspan, Ph.D., VP of research and development. Dr. Grynspan has more than a decade of extensive professional experience in the field of human cell therapy, most recently as VP of R&D for a pioneering cell-therapy company in Israel. She earned a Ph.D. in chemistry/biochemistry from the University of Illinois at Chicago and a postdoctoral degree from Harvard Medical School/McLean Hospital. Maria LUSK Eden Biodesign Expands U.S. Operations Eden Biodesign, a U.K.-based provider of biopharmaceutical process development and cGMP manufacturing services, has appointed Maria Lusk director of client management at its U.S. subsidiary, Eden Biodesign Inc. Most recently, Ms. Lusk was project manager and business development manager at PharmaDirections. Ms. Lusk’s appointment marks the formal establishment of Eden’s U.S. project management function and coincides with the subsidiary’s recent relocation to expanded facilities in Research Triangle Park, N.C. Vincent MIHALIK Former Lilly VP Joins Amylin Leadership Team Amylin Pharmaceuticals has named Vincent Mihalik, senior VP, sales and marketing and chief commercial officer. Amylin is a biopharmaceutical company committed to improving lives through the discovery, development, and commercialization of innovative medicines. Mr. Mihalik oversees marketing and sales for Amylin’s two marketed injectable diabetes therapies, Byetta and Symlin. He also oversees the launch and commercialization of its lead compound, a once-weekly formulation of Byetta’s active ingredient exenatide. Mr. Mihalik was previously Eli Lilly’s VP of global brand development, diabetes and endocrine platform team leader. Dr. Stephen SHREWSBURY AVI BioPharma Hires Chief Medical Officer AVI BioPharma has named Stephen Shrewsbury, M.D., chief medical officer and senior VP of clinical and regulatory affairs. AVI BioPharma is a biopharmaceutical company developing RNA-based drugs for a wide range of diseases and genetic disorders. Dr. Shrewsbury’s 30-year career has spanned medical practice, research, clinical development, and product commercialization. Most recently, Dr. Shrewsbury served as chief medical officer and senior VP, clinical development and regulatory affairs, for Adamas Pharmaceuticals. He qualified at the University of Liverpool’s School of Medical Education. Specialty POOL Dr. Lance BERMAN Former Pfizer Executive Joins CPEX Pharmaceuticals as Medical Chief CPEX Pharmaceuticals has named Lance Berman, M.D., chief medical officer. CPEX is an emerging specialty pharmaceutical company focused on the development, licensing, and commercialization of pharmaceutical products using its validated drug-delivery platform technology. Dr. Berman was most recently senior medical director and global medical team leader at Pfizer. He received his bachelor of medicine and bachelor of surgery at the University of Cape Town and holds a master’s degree in pharmaceutical medicine. Emerging POOL Robert COHEN Michael MCCARTHY Osteotech Expands Senior Management Team Osteotech, a provider of biologic products for regenerative healing, has added Robert Cohen as senior VP of tissue engineering. He spearheads the company’s efforts to translate Osteotech’s investments in technology-based therapies into innovative procedure-related products while also managing direct relationships with surgeon customers. Mr. Cohen most recently served as chief technology officer for Pipeline Biomedical Holdings. He holds an M.S. in engineering management and an M.S. in mechanical engineering from the New Jersey Institute of Technology, and has 25 patents and 35 publications to his credit. Michael McCarthy has been named senior VP of sales, with responsibility for further implementing and managing a sales model that incorporates distributor, channel partner, and direct sales strategies. Mr. McCarthy also joins Osteotech from Pipeline Biomedical, where he served as chief business development officer. Drug Delivery POOL Dr. Sarma DUDDU Cephalon Appoints Head of Cima Labs Cephalon has named Sarma Duddu, Ph.D., general manager and VP of drug delivery technologies of its drug-delivery subsidiary, Cima Labs. Dr. Duddu leads all aspects of the Cephalon drug-delivery business at Cima. Dr. Duddu has more than 15 years of pharmaceutical experience and has been involved in all aspects of the drug delivery business. He most recently served as VP of pharmaceutical development at Nektar Therapeutics. Dr. Duddu earned a Ph.D. in pharmaceutics from the University of Minnesota. Agency POOL Dennis ASCIENZO Cara BANDA Allison FARESE Tom FORBES Terrence ROUSE Staff Changes at Altum Altum has announced a number of promotions and additions to its staff. Altum is a CommonHealth professional advertising and promotion agency focused on the biotechnology and specialty markets. Dennis Ascienzo has joined Altum as a group art director. Previously, Mr. Ascienzo was employed at Becton Dickinson. Altum has hired Cara Banda as an editor and Allison Farese as an account supervisor. Ms. Farese is working on the launch of a new indication for a novel chemotherapy to treat several major cancer types. Tom Forbes has been promoted to senior account executive from account executive. He has responsibility for overseeing day-to-day responsibilities and operations for a leading biologic agent used to treat cancer. Terrence Rouse, a CommonHealth alumnus, joins Altum as senior VP, group strategic planner. Mr. Rouse most recently was a senior manager, market research, at Pharmion, which was acquired in 2008 by Celgene. Matt BROWN Ignite Health Taps GSW Executive as Chief Operating Officer Ignite Health has named Matt Brown chief operating officer. Ignite Health is an inVentiv Health company and marketing agency that specializes in patient-centered medical advertising. Mr. Brown previously served as senior VP and managing director for the Newtown, Pa., office of Ignite’s fellow inVentiv network agency, GSW Worldwide. Gail CHAPMAN Photosound Announces Promotion Photosound has promoted Gail Chapman to account director. Photosound, a HealthSTAR company, is a global medical communications and design agency serving the pharmaceutical industry. Bob DEBARTOLO Keith HIGBEE Steve MARTORANA Neelam TEWAR Cadient Adds Account Staff Cadient Group, an interactive marketing agency serving the healthcare industry, has announced four additions to its staff. Bob DeBartolo has joined Cadient’s West Conshohocken, Pa., headquarters as group account director. Mr. DeBartolo is responsible for managing multiple account teams, as well as contributing to senior management, operations, and business development activities. He most recently oversaw and drove digital innovation for Omnicom’s Das Healthcare network of agencies in the pharmaceutical and healthcare sector. At Cadient’s New York office, Keith Higbee has been named strategic engagement director, with responsibility for strategic planning related to new business projects. Mr. Higbee was previously a partner, account director, at Ogilvy & Mather. Also in New York, Steve Martorana has been appointed account manager. Mr. Martorana joins Cadient from Photosound, where he was an account and business development manager. Neelam Tewar has joined Cadient’s New York office as senior account manager, with responsibility for working on new business development projects. Ms. Tewar previously worked at Grey Healthcare Group. Marilyn GROSS Vanessa SYPKO Centron Appoints Head of Medical Education Full-service medical communications agency Centron, a HealthSTAR company, has hired Marilyn Gross as an executive VP, managing director, and head of Centron’s medical education group. Ms. Gross joins Centron from Euro RSCG Life, where she was president of Medical Education Group and publication practice leader for Catapult Communications. In other staff additions, Vanessa Sypko has been appointed account supervisor. Ms. Sypko was previously account director at Advogent. Alya SHERMAN CMI Announces Executive Promotion Communications Media (CMI) has promoted Alya Sherman to VP, media services, from executive director, media strategies. CMI is an advertising, media, and promotion planning organization focused primarily on the pharmaceutical and related healthcare industry. Michael WONG Davies Names Pharma/Biotech Practice Head Public affairs and strategic communications firm Davies has appointed Michael Wong, J.D., leader of its healthcare team’s recently launched pharma/biotech practice. Mr. Wong was most recently healthcare practice leader for GCI Group. Dr. W. David WOODS New Chief Executive at BioscriptUS London-based Bioscriptstirling, a full-service medical communications company, has appointed W. David Woods, Ph.D., as CEO of its U.S. arm, BioscriptUS. Dr. Woods has spent more than two decades as a medical writer, editor, and publisher, most recently serving as editor-in-chief and director of U.S. corporate relations for a United Kingdom-based medical communications company, as well as editor of the online newsletter Health Outcomes Communicator. Dr. Woods holds a doctorate in health policy and is a fellow of the College of Physicians of Philadelphia. CRO POOL Stephen CIESINSKI James RURKA Two Executives Join SRI International SRI International, an independent, nonprofit research and development organization, has appointed Stephen Ciesinski VP of strategic business development. Mr. Ciesinski oversees SRI’s innovation partnership programs, commercial research and development business development, international offices, corporate energy initiatives, strategic marketing, and other corporate programs. Mr. Ciesinski was most recently chairman and CEO of Laszlo Systems. He received an MBA from Stanford University. In other moves, SRI has named James Rurka executive director, biosciences commercialization. Mr. Rurka is leading efforts to bring SRI’s pharmaceutical products and technologies to the market through licensing and partnership agreements. Before joining SRI, Mr. Rurka was co-owner and chief business officer of privately held biotechnology firm Blanca Pharmaceuticals. Andrew MACGARVEY New U.S. President at Quanticate Quanticate has named Andrew MacGarvey president of its U.S. operations based in Cambridge, Mass. Quanticate is a London-based global biometrics clinical research organization. In this role, Mr. MacGarvey is responsible for managing the company’s initiatives in support of existing and new clients in the United States, as well as continuing to direct its global sales efforts. Before joining Quanticate, Mr. MacGarvey served as a director at Datatrial. Media POOL Lori FLYNN Greg JACKSON Laura KLEIN Carolina PETRINI Scott WOLF Everyday Health Promotes, Expands Online media network Everyday Health has announced several additions and promotions. Lori Flynn has been promoted to VP of sales development. Greg Jackson has advanced to executive VP of marketing and sales operations from senior VP of marketing. Mr. Jackson is responsible for creating and executing marketing strategy and increasing subscriber acquisitions across the Everyday Health network. He holds an MBA in marketing from Rutgers University. Laura Klein has been promoted to senior VP of sales and marketing. Ms. Klein joined Everyday Health in December 2007 as VP of sales. Carolina Petrini has joined Everyday Health as VP of research. She is leading the effort to expand the range of measurement and effectiveness data available to clients. Ms. Petrini was most recently senior VP of marketing solutions for the pharmaceutical and CPG verticals for comScore. The company also has promoted Scott Wolf to executive VP of sales from senior VP of sales. In his three years with Waterfront Media, the company that operates Everyday Health, Mr. Wolf has built up the salesforce from a three-person group to a team of more than 60 online publishing sales professionals. Mr. Wolf has a master’s degree in marketing from New York University’s Leonard N. Stern School of Business. Evan YOUNG Slack Promotes Editor to Director of E-Publishing Evan Young has been promoted to the new position of director of e-publishing for specialty medicine for Slack. Mr. Young was previously executive editor of three Slack publications: Endocrine Today, HemOnc Today, and Cardiology Today. Mr. Young collaborates with editorial, special services, and sales to develop innovative opportunities and solutions in e-publishing for current Websites and for project-specific Web publishing sites. He also is responsible for building registration and increasing traffic on all sites within Slack’s specialty medicine group, leading the development of e-publishing projects, and ensuring existing sites are leaders in their specialty areas. Medical Education POOL Don OVERCASH Questra Med Communications Names President Questra Med Communications has appointed Don Overcash, R.Ph., president. Questra Med Communications specializes in developing evidence-based educational programs that support approved products and on-label indications. Mr. Overcash has more than two decades of senior management experience in healthcare communications, most recently serving as president of Arista Marketing Associates. He holds an MBA from the Keller Graduate School of Management at DeVry University. Service POOL Ajit BAID Research Partnership Relocates U.S. Operations The Research Partnership has appointed Ajit Baid as managing director for its U.S. operations and relocated its U.S. offices to Horsham, Pa. Mr. Baid was previously a senior director of client services for Genactis. The Research Partnership is a London-based, full-service global market research agency dedicated to the pharmaceutical industry. Dr. Ann BICHSEL Dr. Sandra FIELDER Former MGI Pharma Directors Join Prosar Prosar Drug Safety Call Center, a provider of adverse event processing and medical information services, has added two directors to its executive team. Ann Bichsel, Pharm.D., has joined Prosar as director of medical information. Dr. Bichsel brings many years of pharmaceutical experience to Prosar, as well as 20 years of nursing experience. Most recently, Dr. Bichsel was director, medical communications, at MGI Pharma. Sandra Fielder, M.D., has been named director of pharmacovigilance. Dr. Fielder has 17 years of pharmaceutical experience, most recently as medical director, global drug safety and pharmacovigilance, at MGI Pharma. Ryan CARPENTIER Lisa CLUNE Leadership Changes at Kaplan EduNeering Kaplan EduNeering, a provider of compliance and knowledge management solutions, has appointed Ryan Carpentier chief operating officer, with responsibility for leading the company’s sales, marketing, business development, and product development functions. Mr. Carpentier joined EduNeering in 2005 as senior VP of sales. Lisa Clune has been promoted to president from her previous role as senior VP and chief technology officer. Ms. Clune has been with EduNeering since 2006, before its acquisition by Kaplan. Kaplan EduNeering is part of the Kaplan Professional business unit. Jim GRANATO Wilson Health Information Names Marketing VP Consumer insight firm Wilson Health Information (WilsonRx) has appointed Jim Granato VP of sales and marketing. Mr. Granato is helping to lead the company’s expansion into providing marketers with relevant healthcare information, analytics, and research services that allow them to refine their strategic goals and improve their market penetration. Mr. Granato brings a broad range of healthcare brand marketing experience in trade publishing and electronic media to WilsonRx, most recently serving as the publisher of Pharmacy Times. Mary Anne GREENBERG Alliance Healthcare Names CEO Healthcare marketing services company Alliance Healthcare Information, a subsidiary of United Drug, has promoted President and Chief Operating Officer Mary Anne Greenberg to CEO. She succeeds Jack Thorne in this position. Mr. Thorne remains chairman of Alliance Healthcare. Dr. Jeffrey NEW PSI Selects Medical Business VP Pharmaceutical Strategic Initiatives (PSI), a provider of medical affairs strategic consulting and content development services, has hired Jeffrey New, Pharm.D., as VP of medical activities. Dr. New most recently was director of medical and scientific affairs at Dey L.P., a subsidiary of Mylan. Susan TORROELLA Former Columbia MedCom CEO Joins Medex Global Medex Global Group, a provider of travel, security, and medical assistance services, has named Susan Torroella chief operating officer. Ms. Torroella has been charged with leading the expanding company’s 24-hour global operations. Ms. Torroella has more than 20 years of strategic management, marketing, and sales experience in the healthcare industry. She joins Medex after seven years as CEO of Columbia MedCom Group. She received a master’s degree in international management from the Thunderbird School of Global Management. Technology POOL Dr. William HOWARD Kristopher WIGGS Staff Additions at Qforma Qforma, an advanced analytics and predictive modeling company, has appointed physicist William Howard, Ph.D., as director, field operations. Dr. Howard joins Qforma following a diverse career in multiple technical fields. For the past eight years, Dr. Howard has developed and marketed computational lithography products for the semiconductor industry. He received a Ph.D. as a Hertz Foundation Fellow in applied nuclear and medical physics from the Massachusetts Institute of Technology. In other company news, Kristopher Wiggs has been appointed VP of sales, new business. Mr. Wiggs has more than a decade of pharmaceutical industry sales experience, including a stint as district manager with Organon, which is now part of Schering-Plough. F Send your personnel announcements to feedback@pharmavoice.com. Talent Pool executive appointments and promotions in the healthcare industry

Posted in:

Post a Comment

You must be logged in to post a Comment.

FEEDBACK